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Abstract
Background: Brain size and patterning are dependent on dosage-sensitive morphogen signaling pathways – yet
how these pathways are calibrated remains enigmatic. Recent studies point to a new role for microRNAs in tempering
the spatio-temporal range of morphogen functions during development. Here, we investigated the role of miR-135a,
derived from the mir-135a-2 locus, in embryonic forebrain development.
Method: 1. We characterized the expression of miR-135a, and its host gene Rmst, by in situ hybridization (ish). 2. We
conditionally ablated, or activated, beta-catenin in the dorsal forebrain to determine if this pathway was necessary
and/or sufficient for Rmst/miR-135a expression. 3. We performed bioinformatics analysis to unveil the most predicted
pathways targeted by miR-135a. 4. We performed gain and loss of function experiments on mir-135a-2 and analyzed by
ish the expression of key markers of cortical hem, choroid plexus, neocortex and hippocampus.
Results: 1. miR-135a, embedded in the host long non-coding transcript Rmst, is robustly expressed, and functional, in
the medial wall of the embryonic dorsal forebrain, a Wnt and TGFβ/BMP-rich domain. 2. Canonical Wnt/beta-catenin
signaling is critical for the expression of Rmst and miR-135a, and the cortical hem determinant Lmx1a. 3. Bioinformatics
analyses reveal that the Wnt and TGFβ/BMP cascades are among the top predicted pathways targeted by miR-135a.
4. Analysis of mir-135a-2 null embryos showed that dorsal forebrain development appeared normal. In contrast, modest
mir-135a-2 overexpression, in the early dorsal forebrain, resulted in a phenotype resembling that of mutants with Wnt
and TGFβ/BMP deficits - a smaller cortical hem and hippocampus primordium associated with a shorter neocortex as
well as a less convoluted choroid plexus. Interestingly, late overexpression of mir-135a-2 revealed no change.
Conclusions: All together, our data suggests the existence of a Wnt/miR-135a auto-regulatory loop, which could serve
to limit the extent, the duration and/or intensity of the Wnt and, possibly, the TGFβ/BMP pathways.
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Background
MicroRNAs are micro-modulators of gene expression,
eliciting small changes in the expression of a wide array
of targets [1]. In the last ten years, their role in almost every
facet of nervous system development and function has been
considered including neuronal and glial differentiation, syn-
aptogenesis, and neuro-degeneration [2–10]. Yet only re-
cently, some studies have focused on their role in
modulating the dosage or duration of the most fundamental
developmental molecules – morphogens [11, 12]. Given
the exquisite dosage sensitivity of morphogens, an argu-
ment has been proposed that these pathways are prime
substrates for microRNA micro-management [12].
Wnt and TGFβ/BMP morphogens expressed by the
roof plate, or adjacent neuroepithelium, act through sig-
naling cascades implicated in various facets of dorsal
neural tube development [13]. Throughout the Central
Nervous System (CNS), various studies have revealed a
role for Wnt signaling in the expansion of the brain via
increases in cell proliferation and survival [14–18].
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Other studies have revealed roles in specification of key
neuronal progenitor types, as well as in the timing of
neurogenesis [16, 19–22]. Additionally, several studies
have suggested that the dosage of the Wnt pathway is
critical for normal specification, neurogenesis and differ-
entiation [15, 19, 23, 24]. TGFβ/BMP signaling has also
been implicated in proliferation, specification, neurogen-
esis and gliogenesis [25–31]. Akin to the Wnt pathway,
several studies have suggested that the TGFβ/BMP path-
way is exquisitely dosage sensitive [32, 33]. Despite an
emerging literature on the cross talk between these two
key pathways [31, 34], the potential nodes of intersection
and their net molecular outputs remain to be fully
elucidated. It is likely that the molecular synchronization
of these pathways is required for dorsal neural tube
development.
The cortical hem, positioned adjacent to the hippocam-
pus, between the choroid plexus on the medial side and
the cortical neuroepithelium on the lateral side, is a Wnts
and TGFβ/BMPs-rich embryonic structure [29, 35, 36].
The hem has been demonstrated to specify the hippo-
campus primordium [37–42], to serve as a source of
Cajal-Retzius cells [43], to be required for choroid plexus
formation [16, 29, 36] and to play a role in regulating the
size and patterning of the neocortex [44].
Previously, we identified a microRNA, miR-135a,
whose expression was correlated to the long non-coding
transcript Rhabdomyosarcoma 2 associated transcript
(Rmst). We deduced that miR-135a was derived from
mir-135a-2 locus embedded in Rmst and we demon-
strated that Rmst and miR-135a are co-expressed in the
ventral midbrain, isthmus, as well as dorsal regions of
the neural tube [11]. At least in the midbrain, modest
and early overexpression of this microRNA yields phe-
notypes consistent with a reduction of Wnt signaling
[11]. Given the potential importance of this microRNA,
we have explored its expression, activity and induction
in the dorsal forebrain as well as generated mir-135a-2
knockout and overexpressor mice. We reveal that
miR-135a is strongly expressed, and is functional, in the
medial wall of the telencephalon including the cortical
hem and hippocampus primordium, but more weakly
expressed in the choroid plexus and in the neocortex. We
show that canonical Wnt/beta-catenin signaling is critical
for Rmst and miR-135a expression, and also for Lmx1a
expression, a key cortical hem determinant. While
mir-135a-2 loss of function did not result in appreciable
changes in the cortical hem and neocortex sizes or in
choroid plexus complexity, its modest over-expression re-
sulted in smaller cortical hem and neocortical domains
and also in a less convoluted choroid plexus. All together,
our data lead us to conclude that this Wnt induced micro-
RNA is a potential modulator of the Wnt and TGFβ/BMP
signaling pathways during dorsal forebrain development.
Methods
Nomenclature
miRbase uses a 3 or 4 letter prefix to designate the
microRNA species, such that ‘mmu’ refers to the mouse.
The un-capitalized ‘mir’ refers to the pre-microRNA
(mmu-mir-135). In this manuscript, we have only inves-
tigated the murine mir-135 therefore we have omitted
the prefix. Distinct genomic loci that belong to the same
family (mir-135) are typically indicated with an
additional letter and number such as mir-135a-1,
mir-135a-2 and mir-135b. The capitalized ‘miR’ refers to
the mature form (miR-135). mir-135a-1 and mir-135a-2
give rise to only one mature form called mmu-miR-
135a-5p. For simplicity, we will refer to the mature
form as miR-135a. However, our experiments on
mir-135a-2 knockout mice imply that the predominant
mature form of miR-135a in the dorsal forebrain is pro-
duced from the mir-135a-2 locus.
Mouse lines
Animals were maintained in compliance with National
Institutes of Health guidelines. The Northwestern
University IACUC approved the protocols for this study.
E0.5 designates the morning of the day when a vaginal
plug was detected. For beta-catenin gain and loss of
function experiments, Ctnnb1lox(ex3) [45] or beta-catenin
floxed mice (Ctnnb1flox/flox) [46], were crossed with
Emx1::IRES-Cre [47] and embryos were used for in situ
hybridization (ish) or RT-qPCR experiments. The miR-
135a “sensor” construct was previously described [11]. To
evaluate miR-135b expression, we used mir-135bflox/flox
mice (Jackson lab) [48], which harbor a LacZ cassette and
crossed them to wild type females. E12.5 embryos of the
mir-135bflox/+ genotype were stained for Xgal as previ-
ously described [49]. To generate the mir-135a-2 knock-
out mice, we utilized ZFN technology (Sigma). One
advantage of this approach is that no selection cassette or
residual FRT, or loxP sites, will remain in the intron, and
the resultant deletion will be clean. Sixteen different ZFNs
were custom designed to bind and cleave the mir-135a-2
locus, within 100 bp upstream or downstream of the
stem-loop precursor. The ZFN (GCCATCAGGATAGC
nAACTATAGCCTGTGGAC) that demonstrated the
highest activity, in an in vitro Mouse Neuro2a cell screen,
was chosen for large-scale production and microinjection
in mice. The ZFN mRNA was diluted to 2.5 ng/μl in
injection buffer and microinjected into early stage FVB
embryos. 152 mice were screened with ZFN-F: GGTC
CTCGTAGCGAAGAATG and ZFN-R: AATCGGTGGT
CAGGAAGATG PCR primers. Five heterozygous mice
were identified with one wild type allele and one allele
containing a deletion near the mir-135a-2 locus. After
sequence analysis, we found that each deletion was unique
and ranged from 2 bp to 294 bp. Line #4 had the largest
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deletion, which removed the entire mir-135a-2 precursor,
and was used for the experiments here described. RT-
qPCR with TaqMan primers was used to confirm drastic
reduction of the mature form miR-135a.
Sensor transgenic embryos (n = 4), andmir-135a-2 knock-
out (mir-135a-2KO) mice were generated at the Northwestern
Transgenic and Targeted Mutagenesis Laboratory.
Generation and genotyping of mir-135a-2 over-
expressor transgenic mouse line have been previously
described in [11]. To generate conditional mir-135a-2OE
embryos, mir-135a-2OE mouse line was crossed with
Emx1::IRES-Cre (henceforth Emx1::Cre) [47] or Nestin::Cre
(henceforth Nes::Cre) [50]. As controls for these ex-
periments, we used littermates negative for Cre. To
generate Emx1::Cre;mir-135a-2OE;mir-135a-2+/- embryos,
Emx1::Cre;mir-135a-2OE adult mice were crossed with
mir-135a-2 knockout mice.
Tissue processing
Brains were fixed with 4 % PFA and either embedded in
30 % sucrose-10 % gelatin-PBS and sectioned with a Leica
SM2010R sliding microtome, or in OCT and sectioned
with a Leica cryostat. Sections (20–40 μm) were processed
for ish with Digoxigenin (Dig)-labeled riboprobes [43].
Bound Dig was detected with anti-Dig antibody (1:5000,
Roche). To detect Rmst, we used two probes as described
in [11]. To detect miR-135a, we performed locked-nucleic
acid (LNA) ish with Exigon probe # 39037-01 and followed
recommended protocol for non-radioactive hybridization
by Dr. Wigard Kloosterman, the Plasterk Group, Hubrecht
Laboratory, Utrecht, The Netherlands, with the following
modifications: no de-paraffinization step; PK treatment 5’–
10’ at 37C (20-40 μm sections); T hyb 53C; probe [25nM];
blocking solution 10 % lamb serum-TBST; anti-Dig-AP
was diluted 1:5000 in 1 % lamb serum-TBST. eGFP expres-
sion, in double transgenic embryos, was detected by im-
munofluorescence with anti-GFP rabbit polyclonal (1:1500,
Invitrogen) without antigen retrieval on 20 μm cryostat
sections. Secondary antibody was donkey anti-rabbit 488
(Invitrogen). No immunostaining was necessary to detect
tdTomato expression. For Xgal staining, brains were lightly
fixed in 2 % PFA-PIPES solution, washed in PBS and Xgal
stained from few hours to overnight at 37C. To generate
coronal sections, after Xgal staining, brains were fixed in
4 % PFA overnight and processed for cryostat sectioning
(50 μm). For immunohistochemistry (IHC) assay, brains
were also fixed in 4 % PFA overnight and sectioned at
20 μm with a Leica cryostat. After citrate antigen retrieval,
sections were incubated with anti-phospho-Smad 1/5/8
rabbit polyclonal (1:50, Cell signaling). Secondary antibody
was biotinylated anti-rabbit polyclonal from ABC KIT
(1:200, Vectastain). In this study, gene expression compari-
sons between control and mutant mice were based on at
least 3 brains per group per age for each gene.
Quantification of cortical tissue and cortical hem area
At E12.5, the length of the neocortex was measured from
the pallium-subpallium boundary (PSB), chosen as a land-
mark, to the cortical hem. Quantification was performed
at three levels of the brain, 80 μm apart, along the rostro-
caudal axis. At the same stage, we additionally quantified
the cortical hem area (Lmx1a+). For all of the measure-
ments, we used ImageJ software (series 1.4, NIH, public
domain). Data are expressed as a mean ± the standard
error (SEM) (n = 3).
RT-qPCR
For RT-qPCR experiments, dorsal or ventral forebrain
tissue was dissected from controls (wild types) and mu-
tants (Emx1::Cre;Ctnnb1lox(ex3), Emx1::Cre;Ctnnb1 cKO,
mir-135a-2 knockout and overexpressor) (n = 3). Briefly,
E12.5 embryos were collected in ice cold PBS, the fore-
brain was exposed, and a piece of the dorsal, or ventral,
forebrain tissue was snipped with forceps and processed
for RNA extraction. Total RNA, including small RNAs,
was extracted using the mirVana kit (Ambion). To quan-
tify miR-135a and miR-135b expression levels, we used
the TaqMan PCR Assay (ID 000460 and ID 002261, Ap-
plied Biosystems) and normalized our data to microRNA
sno202 (ID 001232, Applied Biosystems).
Statistical analysis
To determine statistical significance of our quantification
experiments, we first determined if data followed the nor-
mal distribution by the Anderson-Darling Test for Normal-
ity. All of our data sets had a p value > 0.05, indicating
normality. To assess the statistical significance of changes
in the cortical hem area and neocortical domain length, the
two experimental groups (control and mutant mice) were
compared with two samples equal variance, two tailed,
Student’s t-test. To calculate the relative fold changes in
miR-135a and miR-135b expression by RT-qPCR experi-
ments, we applied the comparative C(T) method also re-
ferred to as the 2 (-DeltaDeltaC(T)) method [51] and
normalized our data to microRNA sno202. Unpaired Stu-
dent’s t test was applied to determine statistical significance.
Bioinformatics analysis
To determine miR-135a most predicted targeted path-
ways, we used the Diana-miRPath, a microRNA pathway
analysis web server that combines predicted and vali-
dated microRNA targets in CDS or 3’-UTR regions with
sophisticated merging and meta-analysis algorithms [52].
Results
Rmst and miR-135a expression and activity in the
embryonic forebrain
Previously, we identified miR-135a through a screen for
microRNAs that were robustly expressed in the Wnt-rich
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ventral midbrain region of the embryonic Central Nervous
System (CNS) [11]. We provided evidence that miR-135a
expression was correlated with Rmst, and deduced that
miR-135a was derived from mir-135a-2 locus located in
the final detected intron of Rmst [11, 53]. Since the em-
bryonic dorsal forebrain is known to be a Wnt-rich region
and dependent on Wnt signaling [36, 54, 55], we deter-
mined if Rmst and miR-135a were also co-expressed in
this region of the CNS. We therefore first characterized
Rmst expression at embryonic and adult stages (Fig. 1 and
Additional file 1: Figure S1). In embryonic forebrain sec-
tions Rmst is robustly detected in the medial wall of the
telencephalon, encompassing a Wnt and TGFβ/BMP-rich
signaling center, the cortical hem [35, 56]. At E12.5, Rmst
was strongly expressed in the dorsal telencephalon in a
medialHigh to dorso-lateralLow gradient (Fig. 1a). Expres-
sion was robust in the cortical hem and the adjacent
hippocampus primordium. A very weak hybridization
signal was detected in the choroid plexus and along the
neocortical domain. Rmst was also strongly expressed in
the septum, diencephalon, and eminentia thalami. At later
stages, Rmst expression was localized to various forebrain
nuclei, and the fimbria (Additional file 1: Figure S1).
We next performed Locked Nucleic Acid (LNA) ish
experiments to detect mature miR-135a, focusing on the
embryonic forebrain. We found that this microRNA spe-
cies, like Rmst, was expressed in the medial wall of the
telencephalon in a medialHigh to dorso-lateralLow gradient
(Fig. 1b). Expression was robust in the cortical hem and
the adjacent hippocampus primordium. A very weak
hybridization signal was detected in the choroid plexus
and along the neocortical domain. Some signal was also
detected in the LGE, however, since Rmst is not expressed
in this region, this signal could represent cross hybri-
dization with a closely related microRNA. Alternatively, in
this region miR-135a and Rmst expression could be
uncoupled.
To demonstrate that miR-135a is functional in these do-
mains, we generated double transgenic embryos harboring
a “sensor” and a control transgene. A “sensor” construct
contains a constitutively expressed reporter gene (eGFP),
under control of a CAG promoter, and multiple binding
sites for miR-135a in the 3’ UTR region (Fig. 1c, cartoon,
yellow bars). In cells expressing miR-135a, its perfect
complementarity to sequences in the 3’ UTR should result
in suppression of the eGFP reporter. A control transgene
construct contains a tdTomato reporter, but lacks the
miR-135a binding sites and, therefore, should be
Fig. 1 Rmst and miR-135a expression and activity in the embryonic dorsal forebrain. (a-b and d-e). Forebrain coronal sections of E12.5 wild type
(a, b) and double transgenic mice (d, e). a ish for Rmst. b LNA ish for mature miR-135a. d, e Double transgenic embryos harboring eGFP “sensor”
and tdTomato control constructs represented in c (cartoon; yellow bars indicate miR-135a binding sites). d eGFP immunolabeling e tdTomato
fluorescence. ch, cortical hem; hp, hippocampus primordium; cp, choroid plexus; LGE, lateral ganglionic eminences; ncx, neocortex; d, diencephalon.
Scale bar 100 μm
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constitutively active. In E12.5 double transgenic embryos,
we found that the eGFP reporter (Fig. 1d), but not
tdTomato (Fig. 1e), was selectively reduced in the medial
wall of the telencephalon where miR-135a is strongly
expressed, as well as in the choroid plexus and in the dor-
sal neocortical domain, where Rmst and miR-135a are
more weakly expressed. eGFP was also not detected in the
diencephalon (Fig. 1d). Thus, miR-135a is expressed, and
displays activity, in the embryonic dorsal forebrain.
beta-catenin signaling induces Rmst and miR-135a
expression
Previously, we reported that in the embryonic midbrain,
the transcription factor Lmx1b induces Wnt1/Wnt sig-
naling as well as Rmst and mir-135a-2 locus [11]. Since
Lmx1b and Lmx1a are partially redundant, we postu-
lated that Lmx1a might also be a regulator of Rmst and
mir-135a-2. However, since, in the dorsal forebrain,
Rmst and miR-135a expressions exceed the Lmx1a do-
main, one possibility is that in addition to Lmx genes,
Wnt signaling abets the induction of the Rmst and mir-
135a-2 locus. To address this question, we performed
gain and loss of function experiments of beta-catenin, a
key effector of Wnt signaling pathway [57]. Emx1::Cre
mouse line was used to drive recombination throughout
the dorsal, but not ventral, forebrain [47]. For gain of
function experiments, by conditionally deleting beta-
catenin exon 3 (Ctnnb1lox(ex3)), which encompasses
GSK3β phosphorylation sites, we effectively elevated Wnt
signaling [23, 45]. In mutants (Emx1::Cre;Ctnnb1lox(ex3))
(Fig. 2b), but not in controls (Fig. 2a), Rmst was detected
throughout the dorsal forebrain. Conversely, for loss of
function experiments, we conditionally removed exons
2-6 of beta-catenin to prevent formation of a functional
beta-catenin protein thus impairing Wnt signaling [46]. In
mutants (Emx1::Cre;Ctnnb1 cKO) (Fig. 2c), but not in
controls (Fig. 2a), we observed drastic loss of Rmst expres-
sion throughout the dorsal forebrain and in the remaining
cortical hem tissue (Fig. 2c, asterisk). miR-135a expression
levels, quantified by RT-qPCR on E12.5 dissected dorsal
telencephalon, were strongly induced in Emx1::Cre;Ctnn-
b1lox(ex3) mutants, and reduced in Emx1::Cre;Ctnnb1 cKOs
(Fig. 2d). Overall, these data demonstrate that beta-
catenin signaling is necessary and sufficient for Rmst and
miR-135a expression in the dorsal forebrain.
beta-catenin signaling is necessary for Lmx1a expression
We also determined if Lmx1a, a key cortical hem deter-
minant [58], is a target of Wnt/beta-catenin signaling in
the forebrain, as in other brain regions [11, 22, 23]. While
in Emx1::Cre;Ctnnb1lox(ex3) embryos (Fig. 2f), we did not
observe a drastic change in the cortical hem size (Lmx1a+,
Fig. 2f and Wnt3a+, Additional file 2: Figure S2) or in
Lmx1a expression (Fig. 2f) with respect to controls
(Fig. 2e), in Emx1::Cre;Ctnnb1 cKOs, we observed a drastic
reduction of Lmx1a signal in the remaining cortical hem
tissue (Fig. 2g, asterisk). Lmx1a was detected in the chor-
oid plexus of both mutants (Fig. 2f and g). These results
suggest that Wnt/beta-catenin signaling is necessary, but
not sufficient, for Lmx1a expression in the dorsal forebrain.
Given that Lmx1a in part functions to repress Lhx2 [58], a
negative regulator of the hem [39], Wnt/beta-catenin in-
duction of Lmx1a is likely to be an important event in the
cortical hem establishment and/or maintenance.
miR-135a is predicted to target the Wnt and TGFβ/BMP
pathways, but loss of function does not affect dorsal
forebrain development
To begin to elucidate miR-135a functions, we performed
bioinformatics analysis to determine the most common
pathways targeted by miR-135a. To do that, we took
advantage of the Diana–miRPath software [52], which
Fig. 2 Rmst, miR-135a and Lmx1a are altered in beta-catenin mutants. a-c Rmst expression in E12.5 wild type control (a), Emx1::Cre;Ctnnb1lox(ex3)
(b) and Emx1::Cre;Ctnnb1 cKO mutant (c) brains. d Quantification of miR-135a expression levels by RT-qPCR on E12.5 dissected dorsal telencephalon of
control (wild type), Emx1::Cre;Ctnnb1lox(ex3) and Emx1::Cre;Ctnnb1 cKO mutants (n = 3). miR-135a fold induction was normalized to microRNA sno202.
e-g Lmx1a expression in E12.5 controls (e) and beta-catenin mutant (f and g) brains. Asterisks in c and g highlight remaining cortical hem tissue in
Emx1::Cre;Ctnnb1cKO mutants. ***, p value <0.001; **, p < 0.01; *, p < 0.05 cp, choroid plexus; ncx, neocortex; LGE, lateral ganglionic eminences;
d, diencephalon. Scale bar 100 μm
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utilizes predicted, and validated, microRNA targets to
perform a hierarchical clustering of microRNA and
pathways based on their interactions. We found that
Wnt and TGFβ/BMP signaling pathways are among the
top pathways targeted by miR-135a with an extremely
high statistical significance (p value of approximately
2.9E-07 and 3.6E-10, respectively) (Additional file 3:
Figure S3A). It is worth noticing that the genes targeted by
miR-135a in the TGFβ/BMP (Additional file 3: Figure S3B)
and Wnt pathways (Additional file 4: Figure S4) include
ligands, receptors and downstream transcriptional regula-
tors suggesting that this microRNA likely acts through
multiple levels of the Wnt and TGFβ/BMP cascades to
modulate the outcome of their signaling.
To determine the role of miR-135a in embryonic dor-
sal forebrain development, we generated a mouse line in
which mir-135a-2 was deleted by pronuclear injection of
a specific Zn finger nuclease (Fig. 3a and b), designed to
cleave <100 bp from the mature sequence. Of ~60 pups
examined, 1 harbored a ~294 bp deletion (Fig. 3c and d)
and was used to generate a line for the experiments here
described. RT-qPCR on dissected E12.5 dorsal forebrain
tissue confirmed a drastic reduction in miR-135a expres-
sion levels (Fig. 3e). We thus deduced that, in the dorsal
forebrain akin to the ventral midbrain, miR-135a is pre-
dominantly produced from mir-135a-2 locus.
Because a growing literature has described interactions
between microRNAs and long non-coding RNAs
(lncRNAs) as a novel mechanism to regulate gene expres-
sion as well as microRNA function [59–61], we investi-
gated the possibility of an interaction between Rmst and
miR-135a. A search on miRcode web site, which repre-
sents a comprehensive map of putative microRNA target
sites across the GENCODE long non-coding transcrip-
tome [62], indicated lack of miR-135a responsive elements
in Rmst. To confirm the bioinformatics prediction, we
performed ish for Rmst on E12.5 coronal sections of mir-
135a-2 knockout mice and we did not observe any change
in its expression (Fig. 4a and b). These data seem to there-
fore exclude the possibility of Rmst being a potential target
of miR-135a. Next, we performed in situ hybridization
with Lmx1a (Fig. 4c and d), a marker for the cortical hem
and the choroid plexus to investigate any possible change
in proper development of these Wnt and TGFβ/BMP
responsive domains. We did not, however, observe any
apparent change in the cortical hem size (Fig. 4d) as was
also confirmed by quantification analysis at three levels of
the forebrain, equally spaced along the rostro-caudal axis
(referred to as Rostral, Mid and Caudal) (Fig. 4e). No dif-
ference was detected in the extent of the cortical domain
(Fig. 4d), which was again measured at three levels of the
forebrain, equally spaced along the rostro-caudal axis
(Rostral, Mid and Caudal) from the inflection that marks
the pallium-subpallium boundary (PSB), chosen as a
landmark, to the cortical hem (Fig. 4f). No change in the
choroid plexus complexity was observed (Fig. 4d).
The cortical hem is a signaling center known to induce
and pattern the adjacent hippocampus [38, 41]. We
therefore performed in situ hybridization with neuronal
marker NeuroD2 to assess any morphological changes in
the hippocampal complex at post-natal and adult stages
of mir-135a-2 knockouts. No changes were observed
(Fig. 4g-j). These findings clearly demonstrate that, at
least by these criteria, mir-135a-2 loss of function does
not alter forebrain development.
microRNAs often display redundancy with family
members [63, 64]. To determine whether miR-135b, a
closely related microRNA was expressed in a similar do-
main, we obtained mice in which LacZ had been
inserted into the mir-135b locus. In E12.5 whole mount
Fig. 3 mir-135a-2 deletion by ZFN nuclease. a Representation of Rmst
genomic structure. mir-135a-2 is indicated between exons 15 and 16.
b Cartoon of the last intron of Rmst showing the location of mir-135a-2
and the ZFN cut site. Blue arrows show primers designed to detect the
wild type and deleted bands. c Sequence of Rmst genomic region in
which mir-135a-2 is embedded. Deleted region is underlined; PCR
primers are indicated in blue; mir-135a-2 precursor sequence is in
yellow; the ZFN binding site is in uppercases red and in lowercases is
the ZFN cut site. d PCR showing the wild type and the ZFN deleted
bands. e RT-qPCR showing a drastic reduction of miR-135a in E12.5
dissected dorsal forebrain tissue from control and mir-135a-2 null mice
(n = 3). Data are shown as a fold change and have been normalized to
microRNA sno202. ***, p value <0.001
Caronia-Brown et al. Neural Development  (2016) 11:9 Page 6 of 15
Fig. 4 (See legend on next page.)
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(Fig. 5a) and forebrain sections (Fig. 5b and c), we did
not observe any LacZ staining in the dorsal forebrain
(Fig. 5a and b) whereas we found LacZ expression in cells
emanating from the ganglionic eminences in the ventral
forebrain (Fig. 5c). Consistent with this, RT-qPCR ex-
periments for miR-135b on wild type dorsal and ventral
forebrain dissected tissues, revealed a ventral enrichment
of this microRNA (Fig. 5d). These data suggest that
miR-135b does not serve a redundant function in the
dorsal forebrain.
Early mir-135a-2 overexpression affects dorsal forebrain
development
To complement our loss of function results, we took
advantage of previously generated transgenic mice to con-
ditionally express mir-135a-2 for gain of function experi-
ments. This time, we reasoned that if the Wnt/miR-135a
circuitry identified in the midbrain [11] is functionally
conserved in the forebrain, mir-135a-2 overexpression
might result in Wnts related phenotypes. To test this hy-
pothesis, mice in which mir-135a-2 precursor expression
is under control of a CAG promoter [11] (henceforth mir-
135a-2OE), were crossed with Emx1::Cre line [47] to
overexpress mir-135a-2 throughout the Emx1 domain of
the dorsal, but not ventral, forebrain as early as E9.5 [43].
RT-qPCR on dissected E12.5 dorsal forebrain tissue con-
firmed that miR-135a expression levels, in Emx1::Cre;mir-
135a-2OE mutants, were 1.5 fold more than in controls
(Additional file 5: Figure S5). In such mutants we ob-
served a clear reduction in the size of the cortical hem
(Wnt3a+, Wnt8b+) and the hippocampus primordium
(Wnt8b+) (Fig. 6a-d). Additionally, we observed a reduc-
tion in size of the neocortical domain (Fig. 6a-b, dashed
lines), a phenotype previously shown in mice with genetic
ablation of the cortical hem [44, 65], but not reported in
BmpRIA/IB cKOs which display a smaller cortical hem
[42]. The choroid plexus, normally specified by TGFβ/
BMPs [29, 42] and demarcated by rTtr1, was overall less
(See figure on previous page.)
Fig. 4 mir-135a-2 loss of function characterization. a-b E12.5 coronal sections of control (mir-135a-2+/-) and mir-135a-2KO brains (mir-135a-2-/-) processed
for ish for Rmst showing no change in its expression. c-d ish for Lmx1a in control (c) and mir-135a-2KO (d) brains. Dashed lines highlight the cortical hem
area and the neocortical domain size. e Quantification of the cortical hem area (μm2± SEM) along the rostro-caudal axis (n= 3). f Quantification of the
neocortex length (μm± SEM) from the PSB to the hem at the same levels (n= 3). g-j ish for NeuroD2 on coronal sections of post-natal P1 (g-h) and
adult (i-j) control and mutant brains showing no change in hippocampus morphology (boxed in g and h). ch, cortical hem; cp, choroid
plexus; hp, hippocampus; PSB, pallium-subpallium boundary; ncx, neocortex; CA1, CA3, hippocampus fields; DG, dentate gyrus. Scale bar 100 μm in
panels a-d, 400 μm in panels g and h; 200 μm in panels i and j
Fig. 5 miR-135b expression in the embryonic forebrain. a-c Xgal staining of E12.5 whole mount (lateral view) (a) and E12.5 coronal sections (b-c),
showing expression of lacZ exclusively in the ventral forebrain of mir-135bflox/+ mice harboring a LacZ reporter gene in the mir-135b locus. d RT-qPCR
on wild type dorsal and ventral forebrain tissue samples (n = 3). miR-135b fold induction was normalized to microRNA sno202. ***, p value <0.001. LGE,
lateral ganglionic eminences; MGE, medial ganglionic eminences; PSB, pallium-subpallium boundary; ncx, neocortex. Scale 200 μm in panels b and c
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convoluted (Additional file 6: Figure S6). Altogether,
Emx1::Cre;mir-135a-2OE mutants show characteristics
previously described in mice deficient for Wnt or TGFβ/
BMP activity, or in which the cortical hem has been genet-
ically ablated [16, 29, 42, 44, 65, 66], although they display
a milder phenotype.
Next, we quantified the cortical hem area along the
rostro-caudal axis. We estimated a reduction in its size
of ~34 % at rostral level, ~38 % at mid level and ~18 %
at caudal level (Fig. 6e) in mutants compared to con-
trols. Finally, we quantified the extent of the neocortical
domain and found a significant reduction in size of the
mutant neocortices in comparison to controls (Fig. 6f ).
Since the cortical hem and the hippocampus primor-
dium are reduced in Emx1::Cre;mir-135a-2OE embryos,
these mutants showed a significant reduction of all hippo-
campal structures (CA fields and dentate gyrus) from post-
natal stage P1 (Additional file 7: Figure S7, A-B and E) to
adulthood (Additional file 7: Figure S7C and D) when com-
pared to controls.
Finally, we examined the expression of several bioin-
formatically predicted miR-135a targets. Of these, only
phospho-Smad (1/5/8) and Msx2 revealed consistent
changes, showing apparent reduction in their level and
expression domain extent (Additional file 8: Figure S8).
Their reduction might be due to direct repression,
overall net down regulation of these pathways, or both.
Late mir-135a-2 overexpression does not affect dorsal
forebrain development
Conditional transgenes in neural progenitor cells have
been associated with non-specific phenotypes [67]. To
rule out non-specific effects of mir-135a-2 overexpression,
we also overexpressed mir-135a-2 by using Nes::Cre driver
[50], which like Emx1::Cre, is active in the hippocampus
primordium, along the neocortical domain, and reported
to mediate Cre recombination in the hem at ~ E12.5
[10, 68–71]. Nes::Cre driven overexpression of mir-135a-
2 was additionally useful to determine whether the pheno-
type resulting from mir-135a-2 overexpression in Emx1::-
Cre;mir-135a-2OE mice, was time sensitive. In E12.5
(Fig. 6g and h) and E13.5 (Additional file 9: Figure S9)
Nes::Cre;mir-135a-2OE mutants, we did not observed
microcephaly. Both the cortical hem and neocortical
sizes were not affected (Fig. 6i and j). Also, no change
was observed in the choroid plexus (Fig. 6g and h).
These data suggest that late overexpression of this
Fig. 6 Early, but not late, mir-135a-2OE resembles mutants with Wnt deficits. a-d Coronal sections of E12.5 control (mir-135a-2OE) and mutant
(Emx1::Cre;mir-135a-2OE) brains. Wnt3a (a, b) and Wnt8b (c, d) mark the cortical hem (Wnt3a + and Wnt8b+, brackets and arrows) and the
hippocampus (hp) primordium (Wnt8b+, brackets). Dashed lines highlight the neocortex length from the PSB to the hem. g-h Lmx1a expression
in E12.5 control (mir-135a-2OE) and Nes::Cre;mir-135a-2OE mutant brains. Dashed lines highlight the cortical hem area and the neocortical domain
size. e-f and i-j Quantifications of the cortical hem area (μm2 ± SEM) along the rostro-caudal axis (n = 3) and the neocortex length (μm± SEM)
from the PSB to the hem at the same levels (n = 3) in Emx1::Cre;mir-135a-2OE (e and f) and Nes::Cre;mir-135a-2OE (i and j) mutants. ***, p <0.001;
*, p < 0.05. ch, cortical hem; PSB, pallium-subpallium boundary; ncx, neocortex. Scale bar 100 μm in panels a, b and g, h; 50 μm in panels c and d
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microRNA in neural progenitors, does not affect forebrain
development, and that the transgene does not appear to
display significant toxicity in neuronal progenitors.
mir-135a-2 overexpression in mir-135a-2+/- mice does not
result in forebrain abnormalities
To further demonstrate the specificity of our results, we
removed one copy of endogenous mir-135a-2 from
embryos conditionally overexpressing mir-135a-2. We
reasoned that if the phenotype observed in Emx1::Cre;-
mir-135a-2OE mutants is due to mir-135a-2 over-
expression, then, removal of one copy of the endogenous
mir-135a-2 should alleviate this phenotype. E12.5 embryos
of Emx1::Cre;mir-135a-2OE;mir-135a-2+/- (mutants) and
Emx1::Cre;mir-135a-2+/- (controls) genotypes were ana-
lyzed for the expression of Lmx1a (Fig. 7a and b) and
Wnt3a (Additional file 10: Figure S10). The cortical hem
area and the extent of the cortical domain were quantified
as previously described (Fig. 7c and d). No alterations in
these domains and in the choroid plexus were observed,
suggesting that normal miR-135a levels are important for
embryonic forebrain development.
Discussion
From the present study we deduced six prominent con-
clusions. First, miR-135a, and Rmst, are expressed and
functional in the embryonic dorsal forebrain. Second, in
the dorsal forebrain, mature miR-135a is predominantly
derived from the mir-135a-2 locus. Third, miR-135a is
dispensable for forebrain development. Fourth, modest
mir-135a-2 overexpression, within an early but not late
time window, results in a phenotype consistent with Wnt
and TGFβ/BMP signaling deficits – a reduced cortical
hem, hippocampus primordium and neocortex, and a less
convoluted choroid plexus. Fifth, Wnt/beta-catenin
pathway is necessary and sufficient to induce Rmst and
miR-135a expression pointing to the existence of a Wnt/
miR-135a auto-regulatory loop, which could serve to limit
the extent, the duration and/or intensity of the Wnt path-
way. Finally, Wnt/beta-catenin pathway is also necessary
Fig. 7 mir-135a-2OE in mice heterozygous for endogenous mir-135a-2. a-b ish showing Lmx1a expression in E12.5 control (Emx1::Cre;mir-135a-2+/-)
(a) and mutant (Emx1::Cre;mir-135a-2OE;mir-135a-2+/-) (b) brains. Dashed lines highlight the cortical hem area and the neocortical domain size.
c Quantification of the cortical hem area (μm2 ± SEM) along the rostro-caudal axis (n = 3). d Quantification of the neocortex length (μm± SEM)
from the PSB to the hem at the same levels (n = 3). ch, cortical hem; cp, choroid plexus; PSB, pallium-subpallium boundary; ncx, neocortex. Scale
bar 100 μm in panels a and b
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for Lmx1a expression, a key cortical hem determinant. A
model of these interactions is depicted in Fig. 8.
Wnt and TGFβ/BMP morphogens act through gradients
of signaling cascades and have been implicated in various
facets of dorsal neural tube development [16, 19–22].
Several studies have suggested that the dosage of the Wnt
and TGFβ/BMP pathways is critical and has to be tightly
controlled through intricate networks of positive and nega-
tive feedback loops [15, 19, 23, 32, 33]. It is therefore chal-
lenging to understand how these pathways are modulated
in time and space during embryonic development, how
cells receive and integrate multiple signals and whether po-
tential nodes of intersection exist. Recently, it has been
demonstrated that microRNAs contribute to gene net-
works that transform the graded activity of a morphogen
in robust cell fate decisions by establishing context-
dependency, threshold responses and sharpening temporal
and spatial expression patterns [4, 12, 72]. miR-135a and
its host long non-coding transcript, Rmst, were shown to
be expressed and functional in the embryonic Wnt-rich
domain of the midbrain [11]. Here, we have shown that
miR-135a and Rmst are also co-expressed in the Wnt and
TGFβ/BMP-rich domains of the embryonic dorsal fore-
brain suggesting a correlation between this microRNA, the
Wnts and TGFβ/BMPs-rich domains across the embryonic
CNS. Interestingly, akin to several Wnts and TGFβ/BMPs,
strong expression of Rmst in the embryonic hippocampal
primordium declines over time and, at post-natal stages,
become restricted to the fimbria and virtually undetectable
in the adult hippocampus. Rmst expression has also been
detected in human fetal cortical radial glia, suggesting a
conserved role for this locus [73]. Taking together, the
Rmst/miR-135a expression pattern in mice and humans,
the finding that Wnt signaling is indeed able to induce
their expression and the strong bioinformatics predictions,
we postulate that this microRNA might play a role in fine-
tuning the Wnt pathway and, possibly, the TGFβ/BMP
pathway.
Embryos lacking Wnt3a [16], functional LEF1 [66], or
with genetic ablation of the cortical hem [44, 65], display
loss of the hippocampus and shrinkage of the neocortex
[44, 65], while mice with disrupted TGFβ/BMP signaling
fail to develop or properly differentiate the choroid
plexus [29]. Modest mir-135a-2 overexpression appears
to recapitulate these phenotypes, albeit in a milder
fashion. Coupled with the findings that this microRNA
is bioinformatically predicted to target both positive and
negative regulators in the Wnt and TGFβ/BMP path-
ways, the Wnt related phenotypes observed in the mid-
brain [11], and proven interactions between miR-135a
and targets like GSK, Tcf7l2, Ccnd1 and APC in heterol-
ogous systems or cancer cell lines [11, 74–78], we posit
that miR-135a modulates the Wnt and TGFβ/BMP sig-
naling cascade in the developing forebrain.
mir-135a-2 loss of function embryos did not display
overt forebrain phenotypes, at least by the criteria that
we assayed. One plausible explanation comes from the
observation that members of a microRNA family are
often predicted to target the same or overlapping sets of
Fig. 8 Schematic representation of interactions between Lmx1
genes, the Wnt pathway and Rmst/mir-135a-2 [miR-135a]. a In the
embryonic forebrain, canonical Wnt/beta-catenin pathway induces
Rmst/mir-135a-2 [miR-135a], as well as the cortical hem determinant
Lmx1a. miR-135a, in turn, negatively targets Wnt pathway mRNAs
establishing an auto-regulatory loop. miR-135a is also predicted to
target TGFβ/BMP pathway mRNAs as well as other targets. It is possible
that the TGFβ/BMP pathway is also able to induce Rmst/mir-135a-2
[miR-135a] and establish a miR-135a/TGFβ/BMP auto-regulatory loop. It
is also possible that Lmx1a contributes to Rmst/mir-135a-2 [miR-135a]
expression. However, these interactions remain to be demonstrated.
Ultimately, this complex network of positive and negative interactions
plays a role in determining proper dorsal forebrain size (cortical hem,
hippocampus primordium, choroid plexus and neocortex). b A similar
scenario was previously identified in the embryonic midbrain [11]
where Lmx1b drives the expression of Wnt1/Wnt pathway and of
Rmst/mir-135a-2 [miR-135a], which in turn negatively modulates the
levels of Lmx1b, Wnt1/Wnt pathway and other targets. Additionally,
Wnt1/Wnt pathway and Lmx1a interactions have been demonstrated.
All together these interactions are critical for midbrain dopamine
progenitor pool patterning and expansion
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genes and therefore to act in a functionally redundant
manner [63]. Supporting this idea, single microRNA loss
of function or single microRNA silencing, through anti-
sense oligonucleotides and sponge techniques, typically
results in subtle or no phenotypes [64, 79–81]. Because
mir-135b was expressed in the embryonic ventral fore-
brain, we ruled out any compensatory effect due to this
microRNA. We considered the possibility that the other
member of this family, mir-135a-1 might be expressed in
a similar and overlapping pattern. Because mir-135a-1
and mir-135a-2 produce an identical mature form, it is
not possible to analyze their differential expression by
standard techniques. However, RT-qPCR experiments for
mature miR-135a on dorsal forebrain tissue of mir-135a-2
null embryos revealed greatly reduced expression levels.
Therefore, we concluded that the main miR-135a mature
form in the dorsal forebrain could be attributed to mir-
135a-2 precursor. Redundancy, on the other hand, can
either be attributed to very low levels of miR-135a pro-
duced by the mir-135a-1 precursor or to some other
microRNA having a similar seed sequence. This latter,
more likely, possibility has been raised in the recent litera-
ture [82].
Identifying regulators of the Wnt pathway has been
highlighted as an important goal [83]. miR-135a is up
regulated in several tumor types characterized by high
levels of Wnt/beta-catenin signaling, including colorectal
tumors as well as certain subtypes of medulloblastomas
[74, 76]. It is possible that, in these tumors, Wnt signal-
ing, in accordance with our data in the forebrain, in-
duces miR-135a. If so, miR-135a would serve as a useful
marker for aberrant Wnt signaling in these tumors, and
possibly others, and in therapeutic protocols designed to
circumscribe unrestrained Wnt signaling. In colorectal
cancers, miR-135a has been proposed to act as a positive
regulator of Wnt signaling by targeting APC, a key mol-
ecule of the beta-catenin destruction complex [74].
Thus, while it is emerging that this microRNA is intim-
ately correlated with Wnt signaling in the embryonic
CNS ([11]and this work), in tumors [74–76] and in other
cell types with high Wnt signaling [77, 78], it is possible
that the net effect of miR-135a depends on the physio-
logical milieu. Elucidating the targets may reveal how a
single microRNA, predicted to target both positive and
negative regulators of a signaling pathway, may have dis-
tinct outcomes depending on the context. Ultimately, an
array of biochemical and genetic approaches will be
required to accurately define direct miR-135a targets
and the molecular underpinnings of mir-135a-2 mutant
phenotypes.
Finally, our study has highlighted a role for Wnt/
beta-catenin signaling in the expression of cortical
hem determinant Lmx1a, a LIM-homeodomain tran-
scription factor.
Wnt1/Wnt signaling has been shown to form an auto-
regulatory loop with Lmx1a to control dopaminergic
neurons differentiation in the embryonic ventral mid-
brain [22, 23, 84, 85]. In the dorsal embryonic forebrain,
Lmx1a is expressed in the cortical hem, a Wnt-rich
region. While Lmx1a is not required for cortical hem in-
duction, it is critical for proper regulation of cell fate
decisions [58]. In the absence of Lmx1a, the hippocam-
pal selector gene Lhx2 is ectopically expressed in the
cortical hem leading to excessive production of hippo-
campal cells and decreased production of Cajal-Retzius
cells [58]. Here, through gain and loss of function experi-
ments of beta-catenin, we show that, in the dorsal forebrain
akin to the ventral midbrain [22, 24], Wnt/beta-catenin
signaling is necessary, but not sufficient, for Lmx1a ex-
pression. Wnt/beta-catenin induction of Lmx1a is likely
to be a key event in the proper cortical hem cell fate estab-
lishment and/or maintenance.
Additional files
Additional file 1: Figure S1. Rmst expression during forebrain
development. (A-F) Rmst ish on coronal sections of wild type brains from
E11.5 to adult stage. (A) At E11.5, Rmst is expressed in the epithalamus,
medial wall of the dorsal telencephalon, the eminentia thalami, and the
septum. (B) At E12.5 (as in Fig. 1), Rmst was detected in the medial wall
of the telencephalon and in the diandephalon. (C) At E14.5, Rmst is still
highly expressed in the cortical hem and hippocampus primordium,
thalamus and hypothalamus. (D) At E16.5, Rmst expression is high in the
hippocampus and fimbria but low in scattered cells of the migratory
stream. Expression in the thalamus is maintained. (E) At post-natal stages P1,
Rmst is restricted to the fimbria, yet expressed outside of the hippocampal
formation to become virtually undetectable in the hippocampus of adult
mice (F) (hippocampal staining is not considered specific to the Rmst probe).
dm, dorso-medial wall of telencephalon; emT, eminentia thalami; Et,
epithalamus; tel, telencephalon; v3, third ventricle; lv, lateral ventricle;
Sp, septum; d, diencephalon; hp, hippocampus; ch, cortical hem; cp, choroid
plexus; ncx, neocortex; LGE, lateral ganglionic eminences; th, thalamus,
hy, hypothalamus; fm, fimbria; ms, migratory stream; CA1 and CA3,
hippocampal fieds; DG, dentate gyrus. Scale bar 400 μm in panels A,
C and D; 100 μm in panel B; 200 μm in panels E and F. (TIF 1931 kb)
Additional file 2: Figure S2. Wnt3a expression in mice with elevated
beta-catenin. (A-B) Wnt3a in situ hybridization on control (A) and mutant
(Emx1::Cre;Ctnnb1lox(ex3)) E12.5 coronal sections. Brackets highlight the
cortical hem. ch, cortical hem; cp, choroid plexus. Scale bar 100 μm.
(TIF 2822 kb)
Additional file 3: Figure S3. miR-135a bioinformatics analysis. A) Top
pathways targeted by miR-135a. TGFβ/BMP and Wnt signaling pathways
rank at position number 2 and 3 with high statistical significance. P
values and number of genes targeted in each pathway are indicated. B)
Overview of TGFβ/BMP cascade with highlighted, and listed, 16 genes
targeted by miR-135a. It is worth noticing that the number of listed
genes reflects only the data available on the Diana web site and the
algorithm used for the search, as a higher number of putative miR-135a
targets have already been reported using multiple search engines [11].
(TIF 1865 kb)
Additional file 4: Figure S4. miR-135a targets several mRNAs in the
Wnt pathway. Schematic representation of miR-135a predicted targets in
the Wnt signaling pathway, as generated by the Diana-miRPath software
[52]. The 22 genes predicted to be miR-135a targets are highlighted and
listed. As for the TGFβ/BMP pathway, the number of genes here listed
reflects the data available on the Diana web site and the algorithm used
for the search. (TIF 1741 kb)
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Additional file 5: Figure S5. Quantification of miR-135a expression in
Emx1::Cre;mir-135a-2OE mice. RT-qPCR showing a 1.5 fold change in
miR-135a expression level in E12.5 dissected dorsal forebrain tissue from
mutant mice compared to controls (n = 3). Data are shown as a fold change
and have been normalized to microRNA sno202. ***, p value <0.001.
(TIF 145 kb)
Additional file 6: Figure S6. Early mir-135a-2 overexpression affects
choroid plexus development. (A-B) Coronal sections of E12.5 control
(mir-135a2-OE) and mutant brains (Emx1::Cre;mir-135a-2OE) showing
expression of choroid plexus specific marker rTtr1. The dashed red line is
used to highlight the change in choroid plexus complexity. cp, choroid
plexus. Scale bar 100 μm. (TIF 2429 kb)
Additional file 7: Figure S7. Early mir-135a-2 overexpression affects
hippocampus development. (A-D) Coronal sections of post-natal stage P1
and adult brains processed for ish for NeuroD2. Panels A, B show overall
morphology and size of the hippocampus. Asterisks point towards the
pallium-subpallium boundary. Insets show the extent of the hippocampus
from the CA1 field to the tip of the dentate gyrus, quantification of which,
at mid and caudal level of the brain, is reported in panel E. Length is
expressed in μm± SEM (n = 4). Consistent with a reduced cortical hem size
at embryonic stages, the hippocampus was significantly reduced in its
extent in mutant brains with respect to controls. ***, p <0.001.
Abbreviations: pSub, para subiculum; Sub, subiculum; DG, dentate gyrus;
Cng, cingulate cortex. Scale bar 400 μm in panels A and B; 200 μm in panels
C and D. (TIF 2162 kb)
Additional file 8: Figure S8. Expression of bioinformatically predicted
miR-135a targets. (A-D) Coronal sections of E12.5 controls (mir-135a-2OE) and
mutant (Emx1::Cre;mir-135a2-OE) brains, processed for immunohistochemistry
(IHC) (A-B) or in situ hybridization (C, D). phospho-Smad (1/5/8) IHC on
control (A) and mutant (B) brain coronal sections shows reduced signal in
the cortical hem and the choroid plexus domains of mutants (arrowheads).
Panels C and D show a reduced Msx2 expression domain. ch, cortical hem;
cp, choroid plexus. Scale bar 25 μm in panels A and B; 50 μm in panels C
and D. (TIF 5061 kb)
Additional file 9: Figure S9. Late mir-135a-2 overexpression does not
overtly affect forebrain development. Coronal sections of E13.5 control
(mir-135a-2OE) and mutant brains (Nes::Cre;mir-135a-2OE) processed for in
situ hybridization for Lmx1a. Little to no change was observed in the
cortical hem and neocortical domain (dashed lines) or in the choroid
plexus. ch, cortical hem; cp, choroid plexus; ncx, neocortex. Scale bar
400 μm. (TIF 2507 kb)
Additional file 10: Figure S10. Little to no change in cortical hem of
Emx1::Cre;mir-135a-2OE;mir-135a-2+/- mutant mice. (A-B) ish showing
cortical hem marker Wnt3a in E12.5 control (Emx1::Cre;mir-135a-2+/-)
(A) and mutant (Emx1::Cre;mir-135a-2OE;mir-135a-2+/-) (B) brains. ch,
cortical hem. Scale bar 100 μm. (TIF 542 kb)
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